In financial year 2023, Gland Pharma's diluted earnings per share amounted to over 47 Indian rupees. This Indian company was acquired in 2016 by Fosun Pharmaceuticals, a Chinese pharmaceutical company.
Diluted earnings per share of Gland Pharma Limited from financial year 2018 to 2023 (in Indian rupees)
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account.
Starter Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$199 USD / Month *
Professional Account
Full access
Business Solutions including all features.
* Prices do not include sales tax.
Other statistics that may interest you Statistics on
About the industry
10
- Basic Statistic Revenue of Alliance Pharma product brands 2022
- Basic Statistic Revenue of Lundbeck top products 2021-2023
- Premium Statistic Implementation of pharma track & trace in Russia 2019, by stage
- Premium Statistic Total liabilities of the Ipsen group 2014-2019
- Premium Statistic Operating profit of the Ipsen group 2014-2019
- Premium Statistic Consolidated net profit of the Ipsen group 2014-2019
- Basic Statistic Market share of generics in European countries 2021
- Premium Statistic Revenue of the OTC pharmaceuticals industry worldwide 2018-2029
- Basic Statistic Expenditure on prescription pharmaceuticals in Sweden 2009-2022
- Basic Statistic Expenditure on nonprescription pharmaceuticals in Sweden 2009-2022
About the region
10
- Premium Statistic Leading pharmaceutical and drug companies India 2023, by market capitalization
- Basic Statistic EBIT of Godrej Consumer Products FY 2015-2023
- Premium Statistic Hindustan Unilever's return on capital employed FY 2013-2023
- Premium Statistic Hindustan Unilever's investment value FY 2013-2023
- Premium Statistic Hindustan Unilever's earnings per share FY 2013-2023
- Premium Statistic Hindustan Unilever's dividend per share FY 2013-2023
- Premium Statistic Hindustan Unilever's reserves and surplus value FY 2013-2023
- Premium Statistic Hindustan Unilever's gross sales value FY 2013-2023
- Premium Statistic Hindustan Unilever's market capitalization FY 2013-2023
- Premium Statistic Hindustan Unilever's share price in BSE FY 2013-2023
Other regions
10
- Premium Statistic Biopharmaceuticals market value in Latin America 2022-2027
- Premium Statistic Pharmaceuticals production value in Colombia 2014-2020
- Basic Statistic Employment at select top pharmaceutical companies in Denmark 2022
- Premium Statistic Pharmaceutical self-care companies in Sweden 2018, by sales value
- Premium Statistic Noevir's operating income FY 2015-2019
- Basic Statistic Reasons for visiting a community pharmacy in Great Britain 2014
- Basic Statistic Pharmaceutical products and preparations: manufacturers' sales in the UK 2008-2022
- Premium Statistic Leading pharmaceutical preparations manufacturers in Spain in 2021
- Premium Statistic Revenue of the pharmaceutical industry in Italy 2021, by sector
- Basic Statistic Revenue of Lundbeck 2009-2023
Related statistics
10
- Premium Statistic Lupin's net sales FY 2015-2022
- Premium Statistic Cipla's income from operations FY 2014-2023
- Premium Statistic Cipla's profit FY 2009-2023
- Premium Statistic Net profit of major pharma companies India 2024
- Premium Statistic Growth rate of therapy drugs by Cadila Healthcare India 2022
- Premium Statistic Market share of therapy drugs by Cadila Healthcare India 2022
- Premium Statistic Alembic Pharma India revenue 2022, by leading therapy drug
- Premium Statistic MAT of therapies in Indian pharma 2022
- Premium Statistic Distribution of therapies in Indian pharmaceuticals 2022
- Premium Statistic Growth rate of top therapies in Indian pharmaceuticals 2022
Further related statistics
10
- Revenue of the Bank of Communications 2022
- Revenue of AT&T by segment 2017-2023, by quarter
- Total assets of China Vanke 2022
- Return on average common shareholder equity at Goldman Sachs 2009-2023
- Net interest income of Deutsche Bank 2006-2023
- Net revenue from investment banking at Goldman Sachs 2009-2023
- Shareholders equity at Allianz Group 2008-2023
- Total number of shares issued by Allianz Group 2009-2023
- Structure of investment portfolio of Allianz Group 2014-2023
- Sanofi's total assets 2007-2023
Further Content: You might find this interesting as well
Statistics
- Revenue of the Bank of Communications 2022
- Revenue of AT&T by segment 2017-2023, by quarter
- Total assets of China Vanke 2022
- Return on average common shareholder equity at Goldman Sachs 2009-2023
- Net interest income of Deutsche Bank 2006-2023
- Net revenue from investment banking at Goldman Sachs 2009-2023
- Shareholders equity at Allianz Group 2008-2023
- Total number of shares issued by Allianz Group 2009-2023
- Structure of investment portfolio of Allianz Group 2014-2023
- Sanofi's total assets 2007-2023
Gland Pharma. (August 8, 2023). Diluted earnings per share of Gland Pharma Limited from financial year 2018 to 2023 (in Indian rupees) [Graph]. In Statista. Retrieved April 29, 2024, from https://www.statista.com/statistics/1186939/gland-pharma-s-diluted-earnings-per-share/
Gland Pharma. "Diluted earnings per share of Gland Pharma Limited from financial year 2018 to 2023 (in Indian rupees)." Chart. August 8, 2023. Statista. Accessed April 29, 2024. https://www.statista.com/statistics/1186939/gland-pharma-s-diluted-earnings-per-share/
Gland Pharma. (2023). Diluted earnings per share of Gland Pharma Limited from financial year 2018 to 2023 (in Indian rupees). Statista. Statista Inc.. Accessed: April 29, 2024. https://www.statista.com/statistics/1186939/gland-pharma-s-diluted-earnings-per-share/
Gland Pharma. "Diluted Earnings per Share of Gland Pharma Limited from Financial Year 2018 to 2023 (in Indian Rupees)." Statista, Statista Inc., 8 Aug 2023, https://www.statista.com/statistics/1186939/gland-pharma-s-diluted-earnings-per-share/
Gland Pharma, Diluted earnings per share of Gland Pharma Limited from financial year 2018 to 2023 (in Indian rupees) Statista, https://www.statista.com/statistics/1186939/gland-pharma-s-diluted-earnings-per-share/ (last visited April 29, 2024)
Diluted earnings per share of Gland Pharma Limited from financial year 2018 to 2023 (in Indian rupees) [Graph], Gland Pharma, August 8, 2023. [Online]. Available: https://www.statista.com/statistics/1186939/gland-pharma-s-diluted-earnings-per-share/